clindamycin phosphate/benzoyl peroxide/adapalene

FDA Drug Profile — Cabtreo

clindamycin phosphate/benzoyl peroxide/adapalene is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Cabtreo. Available dosage form: gel.

Drug Details

Generic Name
clindamycin phosphate/benzoyl peroxide/adapalene
Brand Names
Cabtreo
Application Number
NDA216632
Sponsor
Bausch Health US LLC
NDC Codes
1
Dosage Forms
GEL
Routes
TOPICAL
Active Ingredients
CLINDAMYCIN PHOSPHATE, BENZOYL PEROXIDE, ADAPALENE

Indications and Usage

1 INDICATIONS AND USAGE CABTREO is indicated for the topical treatment of acne vulgaris in adult and pediatric patients 12 years of age and older. CABTREO is a combination of clindamycin phosphate (a lincosamide antibacterial), adapalene (a retinoid), and benzoyl peroxide indicated for the topical treatment of acne vulgaris in adult and pediatric patients 12 years of age and older. ( 1 )